Eagle Pharmaceuticals (EGRX) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free EGRX Stock Alerts $4.17 +0.01 (+0.24%) (As of 12:19 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEagle Pharmaceuticals (NASDAQ:EGRX) Stock Crosses Below 200-Day Moving Average of $7.01americanbankingnews.com - April 26 at 4:02 AMEagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Floridaglobenewswire.com - April 15 at 7:00 AMEagle Pharmaceuticals faces potential Nasdaq delistinginvesting.com - April 14 at 12:24 AMStocks Slightly Higher as US Mar PPI Climbs Less Than Expectedmsn.com - April 13 at 9:24 AMStocks Mixed as Bond Yields Climbmsn.com - April 13 at 9:24 AMEagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-Kfinance.yahoo.com - April 12 at 7:25 PMEagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-Kglobenewswire.com - April 12 at 4:05 PMEagle Pharmaceuticals to cut 36% of workforcemsn.com - February 29 at 12:59 PMEagle Pharmaceuticals Stock (NASDAQ:EGRX), Short Interest Reportbenzinga.com - February 22 at 7:58 PMEagle Pharmaceuticals Stock (NASDAQ:EGRX) Dividends: History, Yield and Datesbenzinga.com - February 22 at 7:58 PMBrandes Investment Partners LP Boosts Stock Holdings in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)marketbeat.com - February 19 at 1:27 PMEAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Optionsprnewswire.com - February 9 at 12:00 PMThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)stockhouse.com - February 8 at 8:33 PMLevi & Korsinsky Notifies Shareholders of Eagle Pharmaceuticals, Inc.(EGRX) of a Class Action Lawsuit and an Upcoming Deadlinemarkets.businessinsider.com - February 8 at 8:33 PMShareholders that lost money on Eagle Pharmaceuticals, Inc.(EGRX) should contact Levi & Korsinsky about pending Class Action - EGRXmarkets.businessinsider.com - February 8 at 2:15 PMClass Action Filed Against Eagle Pharmaceuticals, Inc. (EGRX) Seeking Recovery for Investors - Contact Levi & Korsinskymarkets.businessinsider.com - February 7 at 3:47 PMSHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class Action Lawsuit and Upcoming Deadlinestockhouse.com - February 6 at 10:37 AM7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmstockhouse.com - February 2 at 3:06 PMEGRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm!barrons.com - February 2 at 10:06 AMAssenagon Asset Management S.A. Has $3.43 Million Stock Position in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)marketbeat.com - February 2 at 5:40 AMINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmstockhouse.com - February 1 at 2:00 PMEagle Pharmaceuticals (NASDAQ:EGRX) Stock Price Passes Below Two Hundred Day Moving Average of $12.10marketbeat.com - February 1 at 3:55 AMEGRX 9-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceuticals (EGRX) Investors with Substantial Losses to Contact Firm Before Feb. 9th Deadline in Securities...markets.businessinsider.com - February 1 at 1:08 AMINVESTOR ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EGRXstockhouse.com - January 31 at 1:45 PMINVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmbarrons.com - January 31 at 1:45 PMINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmstockhouse.com - January 30 at 3:28 PMSHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. (EGRX) Investors of a Class Action Lawsuit and Upcoming Deadlinestockhouse.com - January 30 at 10:28 AMSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceuticals, Inc. - EGRXstockhouse.com - January 28 at 10:13 PMEagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Bermanmarkets.businessinsider.com - January 28 at 12:12 PMEagle Pharmaceuticals Inc (EGRX)investing.com - January 23 at 8:02 AMSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmmarkets.businessinsider.com - January 19 at 6:03 PMEagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfoliofinanznachrichten.de - January 18 at 1:11 PMEagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfoliofinance.yahoo.com - January 18 at 8:11 AMEagle Pharmaceuticals Deadline Remindermarkets.businessinsider.com - January 14 at 12:37 PMSHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EGRXstockhouse.com - January 11 at 2:45 PMSHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investorsmsn.com - January 3 at 8:13 PMROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EGRXbusinesswire.com - January 2 at 6:27 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Eagle Pharmaceuticals, Inc. - EGRXmarkets.businessinsider.com - December 31 at 12:14 PMEagle Pharmaceuticals Shareholder Action Remindermarkets.businessinsider.com - December 22 at 1:28 PMFINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses to Contact the Firmstockhouse.com - December 22 at 8:27 AMDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmstockhouse.com - December 17 at 10:58 PMEagle Pharmaceuticals Ongoing Deadline Alertmarkets.businessinsider.com - December 17 at 12:58 PMSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firmbarrons.com - December 14 at 9:57 PMDeadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)businesswire.com - December 14 at 11:17 AMGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)tmcnet.com - December 13 at 10:16 PMKirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investorstmcnet.com - December 13 at 5:16 PMEagle Pharmaceuticals, Inc. (EGRX) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Eagle Pharmaceuticals, Inc.tmcnet.com - December 13 at 5:16 PMEAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firmfinancialpost.com - December 12 at 10:06 PMThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investorstmcnet.com - December 12 at 4:13 PMEagle Pharmaceuticals (EGRX) Engaged in Accounting Fraud, Investor Suit Alleges - Hagens Bermanmarkets.businessinsider.com - December 12 at 4:13 PM Get Eagle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for EGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy EGRX Media Mentions By Week EGRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EGRX News Sentiment▼0.590.34▲Average Medical News Sentiment EGRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EGRX Articles This Week▼12▲EGRX Articles Average Week Get Eagle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for EGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LTRN News MURA News CELU News IMMX News HCWB News EQ News KZR News MNOV News SCYX News RLYB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EGRX) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
